SK
Saif Khalfan Mohamed Al Hasani
About Saif Khalfan Mohamed Al Hasani
Data last updated:
Saif Khalfan Mohamed Al Hasani is a Director at Immuneel Therapeutics Private Limited (since 2024). The company operates in Healthcare. Immuneel Therapeutics Private Limited reported revenue of ₹2.25 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Immuneel Therapeutics Private Limited U24230KA2018PTC119691 | Director | 29 Aug 2024 | 2018 | ₹2.25 Cr (FY 2024) | Active |
Board colleagues of Saif Khalfan Mohamed Al Hasani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amit Mookim | 07627928 | Immuneel Therapeutics Private Limited | Director |
| Kiran Mazumdar Shaw | 00347229 | Immuneel Therapeutics Private Limited | Director |
| Prem Venkatachalam Pavoor | 05268309 | Immuneel Therapeutics Private Limited | Director |
| Ranjan Ramdas Pai | 00863123 | Immuneel Therapeutics Private Limited | Director |
| Siddhartha Mukherjee | 09548701 | Immuneel Therapeutics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Saif Khalfan Mohamed Al Hasani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Saif Khalfan Mohamed Al Hasani
Saif Khalfan Mohamed Al Hasani currently holds 1 directorship: Immuneel Therapeutics Private Limited (Director, since 29 Aug 2024, revenue ₹2.25 Cr (FY 2024)).
Saif Khalfan Mohamed Al Hasani was first appointed on 29 Aug 2024 as Director at Immuneel Therapeutics Private Limited.
The current boards of Saif Khalfan Mohamed Al Hasani's companies include Amit Mookim (Immuneel Therapeutics Private Limited), Kiran Mazumdar Shaw (Immuneel Therapeutics Private Limited), Prem Venkatachalam Pavoor (Immuneel Therapeutics Private Limited), Ranjan Ramdas Pai (Immuneel Therapeutics Private Limited), Siddhartha Mukherjee (Immuneel Therapeutics Private Limited).